OBSERVER
Michael Kern
Michael currently serves as Managing Director and Head of Finance & Strategy at HAL Allergy Group, where amongst others he leads Finance, Strategy, Business Development and oversees the activities of Hx Bio Ventures.
Prior to joining HAL Allergy, Michael held senior finance positions at Evotec, a pharmaceutical contract research organization, and advised international Life Sciences clients as a strategy consultant. He holds a Master’s degree in Physics from Ulm University.